Compare BNZI & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNZI | VVOS |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 15.1M |
| IPO Year | N/A | 2020 |
| Metric | BNZI | VVOS |
|---|---|---|
| Price | $0.56 | $1.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $24.00 | $2.75 |
| AVG Volume (30 Days) | ★ 810.9K | 238.9K |
| Earning Date | 05-14-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | $41.28 | $69.66 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.52 | $0.96 |
| 52 Week High | $4.44 | $7.40 |
| Indicator | BNZI | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 41.27 |
| Support Level | $0.53 | N/A |
| Resistance Level | $0.76 | $1.50 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 11.43 | 15.50 |
Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.